Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=28653068
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28653068
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Org+Biomol+Chem
2017 ; 15
(27
): 5656-5668
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Targeting heparin and heparan sulfate protein interactions
#MMPMID28653068
Weiss RJ
; Esko JD
; Tor Y
Org Biomol Chem
2017[Jul]; 15
(27
): 5656-5668
PMID28653068
show ga
Heparin and heparan sulfate glycosaminoglycans are long, linear polysaccharides
that are made up of alternating dissacharide sequences of sulfated uronic acid
and amino sugars. Unlike heparin, which is only found in mast cells, heparan
sulfate is ubiquitously expressed on the cell surface and in the extracellular
matrix of all animal cells. These negatively-charged glycans play essential roles
in important cellular functions such as cell growth, adhesion, angiogenesis, and
blood coagulation. These biomolecules are also involved in pathophysiological
conditions such as pathogen infection and human disease. This review discusses
past and current methods for targeting these complex biomolecules as a novel
therapeutic strategy to treating disorders such as cancer, neurodegenerative
diseases, and infection.